BPMC
Blueprint Medicines Corp
Price:  
128.40 
USD
Volume:  
1,937,572.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BPMC EV/EBITDA

-122.9%
Upside

As of 2025-07-09, the EV/EBITDA ratio of Blueprint Medicines Corp (BPMC) is -54.29. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BPMC's latest enterprise value is 8,557.57 mil USD. BPMC's TTM EBITDA according to its financial statements is -157.63 mil USD. Dividing these 2 quantities gives us the above BPMC EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.2x - 10.7x 9.4x
Forward P/E multiples 9.4x - 11.8x 11.4x
Fair Price (27.10) - (30.13) (29.37)
Upside -121.1% - -123.5% -122.9%
128.40 USD
Stock Price
(29.37) USD
Fair Price

BPMC EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-03 -54.27
2025-07-02 -54.21
2025-07-01 -54.27
2025-06-30 -54.20
2025-06-27 -54.17
2025-06-26 -54.19
2025-06-25 -54.23
2025-06-24 -54.23
2025-06-23 -54.29
2025-06-20 -54.21
2025-06-18 -54.18
2025-06-17 -54.22
2025-06-16 -54.23
2025-06-13 -54.11
2025-06-12 -54.21
2025-06-11 -54.11
2025-06-10 -54.11
2025-06-09 -54.11
2025-06-06 -54.06
2025-06-05 -54.09
2025-06-04 -54.17
2025-06-03 -53.96
2025-06-02 -54.04
2025-05-30 -43.21
2025-05-29 -43.91
2025-05-28 -40.73
2025-05-27 -42.68
2025-05-23 -43.27
2025-05-22 -42.79
2025-05-21 -43.27
2025-05-20 -43.88
2025-05-19 -43.15
2025-05-16 -43.35
2025-05-15 -42.45
2025-05-14 -41.63
2025-05-13 -42.41
2025-05-12 -42.78
2025-05-09 -41.50
2025-05-08 -42.15
2025-05-07 -42.57
2025-05-06 -42.31
2025-05-05 -43.41
2025-05-02 -44.56
2025-05-01 -42.35
2025-04-30 -38.35
2025-04-29 -37.93
2025-04-28 -37.95
2025-04-25 -37.60
2025-04-24 -36.96
2025-04-23 -36.84